An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis
Clinical trial NCT02601300 · COMPLETED
Trial details
- NCT number
- NCT02601300
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-14
- Primary completion
- 2016-09-06
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.